Mike Edwards Is the Subject of a New Interview
The career corporate executive sat down with a freelance journalist to discuss his life, his…
The career corporate executive sat down with a freelance journalist to discuss his life, his…
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / August 17, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR)…
STOCKHOLM, SE / ACCESSWIRE / August 17, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma…
SARNIA, ON / ACCESSWIRE / August 17, 2021 / Aduro Clean Technologies Inc. (CSE:ACT)(OTCQB:ACTHF)(FSE:9D50) (the…
StageZero to Expand Capabilities in Early Diagnosis and Prevention of Cancer and Other Diseases as…
Second Quarter revenue grows 41.1% Year over Year to $65.4 million Renewables segment continues strong…
Delivery achieved significantly ahead of schedule, despite the need to navigate challenges such as the…
THR-687 is a potent pan-RGD integrin antagonist holding potential as next generation first line therapy…
Nasally administered Foralumab, once a day for 10 consecutive days, was well-tolerated and produced significant…
CHF 46.1 million (+26% year-on-year) non-deferred Cresemba and Zevtera revenue, including CHF 23.6 million royalty…
ORION CORPORATION Â Â Â Â Â Â Â Â Â PRESS RELEASE Â Â Â Â Â Â Â Â Â Â Â Â Â 17 AUGUST 2021 at 8.00. a.m. EEST Orion will…
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Continued strength in unit demand across key product lines Rupall unit demand growth of 44%…
PORTLAND, Ore., Aug. 16, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings…
Secured funding of approximately $138 million through merger and private placement investment in public equity…
EMERYVILLE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX) today announced that the compensation…
Corvus Partner Angel Pharmaceuticals Plans to Initiate Trial by Year-end 2021 BURLINGAME, Calif., Aug. 16,…
Lowell Reports 37% sequential growth in revenue driven by large cultivation yields advances and strong…
Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0,…